These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 36077506)

  • 1. Circulating Endothelial Cells: A New Possible Marker of Endothelial Damage in Kawasaki Disease, Multisystem Inflammatory Syndrome in Children and Acute SARS-CoV-2 Infection.
    Fabi M; Petrovic B; Andreozzi L; Corinaldesi E; Filice E; Biagi C; Rizzello A; Mattesini BE; Bugani S; Lanari M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
    Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
    Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
    Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.
    Noval Rivas M; Arditi M
    Rheum Dis Clin North Am; 2023 Aug; 49(3):647-659. PubMed ID: 37331738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
    Zhang QY; Xu BW; Du JB
    World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic.
    Alkan F; Bircan O; Bal A; Bayturan S; Zengin N; Coskun S
    BMC Pediatr; 2024 Jul; 24(1):485. PubMed ID: 39080588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient anti-cytokine autoantibodies superimpose the hyperinflammatory response in Kawasaki disease and multisystem inflammatory syndrome in children: a comparative cohort study on correlates of disease.
    Netea SA; Biesbroek G; van Stijn D; Ijspeert H; van der Made CI; Jansen MH; Geissler J; van den Berg JMM; van der Kuip M; Gruppen MP; Schonenberg-Meinema D; Kapitein B; van Furth AMMT; Nagelkerke SQ; Pajkrt D; Plötz FB; den Boer MEJL; Landman GW; van Houten MA; Goetschalckx I; ; Toonen EJM; van de Veerdonk FL; Kuipers IM; Dik WA; Kuijpers TW
    EBioMedicine; 2023 Sep; 95():104736. PubMed ID: 37524002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection in the context of Kawasaki disease and multisystem inflammatory syndrome in children.
    Folga BA; Karpenko CJ; Grygiel-Górniak B
    Med Microbiol Immunol; 2023 Feb; 212(1):3-12. PubMed ID: 36396785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A12 on circulating endothelial cells surface in children with Kawasaki disease.
    Fu S; Gong F; Xie C; Zhu W; Wang W; Shen H; Tang Y
    Pediatr Res; 2010 Aug; 68(2):165-8. PubMed ID: 20461025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease.
    Zhou C; Zhao Y; Wang X; Huang Y; Tang X; Tang L
    Pediatr Pulmonol; 2021 Dec; 56(12):3688-3698. PubMed ID: 34583417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of Kawasaki disease and multisystem inflammatory syndrome in pediatric patients with COVID-19 infection: A TriNetX based cohort study.
    Chien KJ; Wei CJ; Huang SH; Chen CY; Kuo HC; Hung YM; Liao PL; Huang JY; Cheng MF; Weng KP
    J Chin Med Assoc; 2024 Sep; 87(9):861-869. PubMed ID: 39017646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group.
    Yilmaz Ciftdogan D; Ekemen Keles Y; Cetin BS; Dalgic Karabulut N; Emiroglu M; Bagci Z; Buyukcam A; Erdeniz EH; Arga G; Yesil E; Cakici O; Karbuz A; Sahbudak Bal Z; Kara SS; Ozer A; Metin Akcan O; Elmas Bozdemir S; Anil AB; Uygun H; Kilic O; Hancerli Torun S; Umit Z; Sutcu M; Ozgokce Ozmen B; Karaoglu Asrak H; Alkan G; Kara Aksay A; Ugur C; Birbilen AZ; Bursal Duramaz B; Akyuz Ozkan E; Burakay O; Yildirim Arslan S; Karadag Oncel E; Celik SF; Kilic AO; Ozen S; Sarikaya R; Demirkol D; Arslan G; Turel O; Sert A; Sari E; Orbak Z; Sahin IO; Varan C; Akturk H; Tuter Oz SK; Durak F; Oflaz MB; Kara M; Karpuz D; Talip Petmezci M; Hatipoglu N; Oncel S; Turgut M; Elmali F; Somer A; Kuyucu N; Dinleyici EC; Kurugöl Z; Ciftci E; Kara A
    Eur J Pediatr; 2022 May; 181(5):2031-2043. PubMed ID: 35129668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Characteristics and Outcomes of Multisystem Inflammatory Syndrome, Kawasaki Disease and Toxic Shock Syndrome in Children.
    Klavina L; Smane L; Kivite-Urtane A; Vasilevska L; Davidsone Z; Smitins E; Gardovska D; Lubaua I; Roge I; Pucuka Z; Meiere A; Pavare J
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984627
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
    Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
    Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Laboratory Characteristics of Kawasaki Disease and COVID-19-Related Multisystem Inflammatory Syndrome in Children.
    Phi DL; Dao TL; To MM; Nguyen TB; Nguyen DC; Gautret P; Hoang VT
    J Korean Med Sci; 2023 Dec; 38(49):e410. PubMed ID: 38111281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus disease 2019-associated multisystem inflammatory syndrome and Kawasaki disease.
    Uejima Y; Suganuma E; Matsunaga K; Kitajima I; Niimi H
    Pediatr Int; 2022 Jan; 64(1):e15349. PubMed ID: 36348517
    [No Abstract]   [Full Text] [Related]  

  • 18. Multisystem Inflammatory Syndrome in Children.
    Waseem M; Shariff MA; Lim CA; Nunez J; Narayanan N; Patel K; Tay ET
    West J Emerg Med; 2022 Jul; 23(4):505-513. PubMed ID: 35980407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning about Kawasaki disease from COVID-19 and the Multisystem Inflammatory Syndrome in Children.
    Gorelik M
    Curr Opin Pediatr; 2021 Dec; 33(6):603-609. PubMed ID: 34310359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.
    Esteve-Sole A; Anton J; Pino-Ramirez RM; Sanchez-Manubens J; Fumadó V; Fortuny C; Rios-Barnes M; Sanchez-de-Toledo J; Girona-Alarcón M; Mosquera JM; Ricart S; Launes C; de Sevilla MF; Jou C; Muñoz-Almagro C; González-Roca E; Vergara A; Carrillo J; Juan M; Cuadras D; Noguera-Julian A; Jordan I; Alsina L
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.